ELA vs. LLY
ELA (Envela Corporation) and LLY (Eli Lilly and Company) are both stocks. ELA operates in Luxury Goods (Consumer Cyclical), while LLY operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, ELA returned 44.94%/yr vs 32.66%/yr for LLY. At a 0.04 correlation, their price movements are largely independent.
Performance
ELA vs. LLY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ELA achieves a 80.34% return, which is significantly higher than LLY's 0.72% return. Over the past 10 years, ELA has outperformed LLY with an annualized return of 44.94%, while LLY has yielded a comparatively lower 32.66% annualized return.
ELA
- 1D
- -2.07%
- 1M
- 43.97%
- YTD
- 80.34%
- 6M
- 84.76%
- 1Y
- 318.20%
- 3Y*
- 47.63%
- 5Y*
- 36.35%
- 10Y*
- 44.94%
LLY
- 1D
- 1.37%
- 1M
- 11.64%
- YTD
- 0.72%
- 6M
- 4.73%
- 1Y
- 44.70%
- 3Y*
- 35.56%
- 5Y*
- 41.13%
- 10Y*
- 32.66%
ELA vs. LLY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ELA Envela Corporation | 80.34% | 86.35% | 47.74% | -7.60% | 29.24% | -21.73% | 285.19% | 193.54% | -50.55% | -25.00% |
LLY Eli Lilly and Company | 0.72% | 40.25% | 33.30% | 60.91% | 34.26% | 66.08% | 31.04% | 16.14% | 40.45% | 17.83% |
Correlation
The correlation between ELA and LLY is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Mar 20, 1992 | 0.04 |
The correlation between ELA and LLY shifts across timeframes, from 0.04 (all time) to 0.15 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
ELA:
$626.50M
LLY:
$966.48B
ELA:
$0.81
LLY:
$28.14
ELA:
29.93
LLY:
38.33
ELA:
1.04
LLY:
0.77
ELA:
2.15
LLY:
13.41
ELA:
8.25
LLY:
30.98
ELA:
$291.15M
LLY:
$72.25B
ELA:
$62.58M
LLY:
$59.75B
ELA:
$22.99M
LLY:
$32.97B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ELA vs. LLY — Risk / Return Rank
ELA
LLY
ELA vs. LLY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Envela Corporation (ELA) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ELA | LLY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.32 | ||
| Sortino ratioReturn per unit of downside risk | +2.79 | ||
| Omega ratioGain probability vs. loss probability | 1.58 | 1.24 | +0.34 |
| Calmar ratioReturn relative to maximum drawdown | 14.73 | 1.90 | +12.83 |
| Martin ratioReturn relative to average drawdown | 46.47 | 4.73 | +41.74 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ELA | LLY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 4.50 | 1.19 | +3.32 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.67 | 1.26 | -0.59 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.68 | 1.09 | -0.41 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.08 | 0.57 | -0.50 |
Drawdowns
ELA vs. LLY - Drawdown Comparison
The maximum ELA drawdown since its inception was -97.32%, which is greater than LLY's maximum drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for ELA and LLY.
Loading charts...
Drawdown Indicators
| ELA | LLY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.32% | -68.24% | -29.08% |
Max Drawdown (1Y)Largest decline over 1 year | -21.77% | -23.64% | +1.87% |
Max Drawdown (3Y)Largest decline over 3 years | -59.24% | -34.48% | -24.76% |
Max Drawdown (5Y)Largest decline over 5 years | -61.53% | -34.48% | -27.05% |
Max Drawdown (10Y)Largest decline over 10 years | -78.03% | -34.48% | -43.55% |
Current DrawdownCurrent decline from peak | -12.29% | -4.26% | -8.03% |
Average DrawdownAverage peak-to-trough decline | -57.66% | -19.22% | -38.44% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.90% | 9.49% | -2.59% |
Volatility
ELA vs. LLY - Volatility Comparison
Envela Corporation (ELA) has a higher volatility of 28.22% compared to Eli Lilly and Company (LLY) at 9.16%. This indicates that ELA's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ELA | LLY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 28.22% | 9.16% | +19.06% |
Volatility (6M)Calculated over the trailing 6-month period | 59.00% | 26.81% | +32.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 71.22% | 37.88% | +33.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 54.38% | 32.79% | +21.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 66.24% | 30.14% | +36.10% |
Dividends
ELA vs. LLY - Dividend Comparison
ELA has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.60%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ELA Envela Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LLY Eli Lilly and Company | 0.60% | 0.56% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% |
Financials
ELA vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between Envela Corporation and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ELA vs. LLY - Profitability Comparison
ELA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Envela Corporation reported a gross profit of 20.62M and revenue of 98.38M. Therefore, the gross margin over that period was 21.0%.
LLY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.
ELA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Envela Corporation reported an operating income of 11.21M and revenue of 98.38M, resulting in an operating margin of 11.4%.
LLY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.
ELA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Envela Corporation reported a net income of 8.84M and revenue of 98.38M, resulting in a net margin of 9.0%.
LLY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.
Frequently Asked Questions
ELA and LLY have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ELA has higher volatility (28.22%) compared to LLY (9.16%). In terms of maximum drawdown, ELA dropped -97.32% vs LLY's -68.24%.
ELA currently has the higher Sharpe Ratio (4.50 vs 1.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ELA and LLY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer